AdvanSix(ASIX) - 2024 Q2 - Quarterly Report

Sales Performance - Sales increased by approximately 6% in the three months ended June 30, 2024, driven by higher sales volume of nylon and ammonium sulfate, and favorable pricing in acetone[90]. - Sales decreased by approximately 5% in the six months ended June 30, 2024, primarily due to unfavorable market-based pricing and a decrease in sales volume resulting from an operational disruption[91]. Operational Disruptions - The operational disruption in January 2024 at the Frankford manufacturing site resulted in a pre-tax income impact of approximately $27 million due to lost sales and additional costs[85]. - The company’s integrated supply chain allows for efficient production, but also exposes it to risks associated with disruptions at any production facility[84]. - The company aims to mitigate risks of production interruptions through planned maintenance and buffer inventory strategies[84]. Financial Performance - Net income for the three months ended June 30, 2024, was$38.9 million, up from $32.7 million in the corresponding prior year period[100]. - Adjusted EBITDA for the three months ended June 30, 2024, was$78.1 million, compared to $65.8 million in the prior year[104]. - Adjusted EBITDA margin increased to 17.2$1.43, compared to $1.16 in the prior year[105]. Costs and Expenses - Costs of goods sold increased by$12.1 million (approximately 3%) in the three months ended June 30, 2024, due to increased sales volume[92]. - Selling, general and administrative expenses remained relatively flat at $24.4 million in the three months ended June 30, 2024, compared to$24.0 million in the prior year[95]. - Income tax expense for the three months ended June 30, 2024, was $13.1 million, with an effective tax rate of 25.2$22.6 million for the six months ended June 30, 2024, primarily due to a $46.2 million decrease in net income[125]. - Cash used for investing activities increased by$26.7 million for the six months ended June 30, 2024, mainly due to higher capital expenditures of approximately $25 million[126]. - Capital expenditures for 2024 are expected to be between$140 million and $150 million, an increase from$107 million in 2023[109]. - Cash paid for capital expenditures for the six months ended June 30, 2024, was $68,883[127]. Shareholder Returns and Debt - The company has repurchased a total of 6,250,181 shares of common stock for an aggregate of$192.4 million at a weighted average market price of $30.78 per share[113]. - Dividends announced in 2024 include$0.16 per share for a total approximate dividend amount of $4.3 million for each of the three announcements[116]. - The company had a borrowed balance of$230 million under the revolving credit facility as of June 30, 2024, after borrowing an incremental net amount of $60 million during the first half of the year[123]. - The company is in compliance with all covenants of its credit agreement as of June 30, 2024[122]. Market and Industry Insights - The company is the world's largest single-site producer of both caprolactam and ammonium sulfate fertilizer as of June 30, 2024[76][77]. - Ammonium sulfate industry prices in the corn belt have declined approximately 10$0 to $2 million to the defined benefit pension plan in 2024[111]. - The company utilizes supply chain financing and trade receivables discount arrangements to enhance liquidity and manage working capital needs[107]. - A 25-basis point fluctuation in interest rates would result in an increase or decrease to interest expense of approximately$0.6 million for the six months ended June 30, 2024[131].